Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
A series of 101 consecutive patients with chronic myeloproliferative disorders including polycythaemia vera, chronic myelogenous leukaemia, idiopathic myelofibrosis and essential thrombocythaemia have been studied. The aim was to establish the incidence of thrombotic and haemorrhagic complications and the possible role played by platelet number and function. The total incidence of haemostatic complications was 21% and the platelet functional tests investigated (platelet aggregation, generation of malondialdehyde, endogenous serotonin, beta-thromboglobulin and platelet coagulant activity) were of little help for predicting these clinical complications.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000502:physiology*; D005260:Female; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood / Q000150:complications; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood / Q000150:complications*; D010976:Platelet Count; D010979:Platelet Function Tests; D011087:Polycythemia Vera / Q000097:blood / Q000150:complications; D055728:Primary Myelofibrosis / Q000097:blood / Q000150:complications; D013920:Thrombocythemia, Essential / Q000097:blood / Q000150:complications; D013927:Thrombosis / Q000209:etiology*